ZAP70 antibody (full length)
Quick Overview for ZAP70 antibody (full length) (ABIN3024076)
Target
See all ZAP70 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- full length
-
Purpose
- ZAP70 Antibody Cocktail (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the ZAP70 antibody cocktail.
-
Isotype
- IgG2a, kappa
-
-
-
-
Application Notes
-
Optimal dilution of the ZAP70 antibody cocktail should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Tris with 1 mM EDTA, pH 9, for 10-20 min followed by cooling at RT for 20 min.
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the ZAP70 antibody cocktail at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- ZAP70 (zeta-Chain (TCR) Associated Protein Kinase 70kDa (ZAP70))
-
Alternative Name
- ZAP70
-
Background
- ZAP70 is a 70 kDa protein tyrosine kinase found in T-cells and natural killer cells. Control of this protein translation is via the IgVH gene. ZAP70 protein is expressed in leukemic cells of approximately 25 % of chronic lymphocytic leukemia (CLL) cases as well. Anti-ZAP70 expression is an excellent surrogate marker for the distinction between the Ig-mutated (anti-ZAP70 negative) and Ig-unmutated (anti-ZAP70 positive) CLL subtypes and can identify patient groups with divergent clinical courses. The anti-ZAP70 positive Ig-unmutated CLL cases have been shown to have a poorer prognosis.
-
UniProt
- P43403
-
Pathways
- TCR Signaling, Ubiquitin Proteasome Pathway
Target
-